Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02890342 · ClinicalTrials.gov registry record
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
A clinical trial of Metabolic Disease and Propionic Acidemia, sponsored by National Human Genome Research Institute (NHGRI).
- Recruiting
- Registry status
- 1,045
- Enrollment target
- 2
- Study locations
NCT02890342 is a study of Metabolic Disease and Propionic Acidemia that is actively recruiting participants, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 1,045 participants, below the 4,158-participant average among 33 other Metabolic Disease trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02890342, a study of Metabolic Disease and Propionic Acidemia, is actively recruiting participants, sponsored by National Human Genome Research Institute (NHGRI).
- RECRUITING
- Registry status
- 1,045 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: People s bodies need to break down food into the chemicals. These chemicals are used for energy and growth. Some people cannot process all chemicals very well. Too much of some chemicals can cause diseases. One of these diseases is called propionic acidemia (PA). People with PA can have problems with growth, learning heart, abdomen, and other organs. Researchers want to better understand how these problems happen. Objective: To learn more about propionic acidemia and the genes that might contribute to it. Eligibility: People at least 2 years old with PA who can travel to the clinic Some unaffected family members Design: Participants will have a 3 to 5-day hospital visit every year or every few years. Family members may have just 1 visit. During the family member visit, they may have: Medical history Physical exam Samples of blood and urine Questions about diet and a food diary Doctors and nurses may do additional studies: Samples of saliva, skin and stool Fluid from a gastronomy tube, if participants have one Dental and eye evaluations A kidney test - a small amount of dye will be injected and blood will be collected. Consultations with specialists A test of calories needed at rest. A clear plastic tent is placed over the participant to measure breathing. Stable isotope study. Participants will take a nonradioactive substance then blow into a bag. Photos taken of the face and body with underwear on Ultrasound of the abdomen Heart tests Hand x-ray Brain scan Participants may have other tests if study doctors recommend them. They will get the results of standard medical tests and genetic tests.
Conditions Studied
Study Locations (2)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,045 participants |
| Start Date | 2016-11-29 |
| Est. Completion | 2036-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02890342
The ClinicalTrials.gov registry entry for NCT02890342 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,045 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,158-participant average among 33 other Metabolic Disease trials with a reported enrollment target (75% lower). The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Metabolic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02890342 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02890342 about?
NCT02890342 is a clinical study titled "Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia". Background: People s bodies need to break down food into the chemicals. These chemicals are used for energy and growth. Some people cannot process all chemicals very well. Too much of some chemicals can cause diseases. One of these diseases is called propionic acidemia (PA). People with PA can have...
What is the current status of trial NCT02890342?
This trial is currently recruiting. The enrollment target is 1,045 participants. The study started on 2016-11-29. Estimated completion is 2036-08-31.
What conditions does trial NCT02890342 study?
This clinical trial studies the following conditions: Metabolic Disease, Propionic Acidemia, Organic Acidemia.
Who is sponsoring clinical trial NCT02890342?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02890342 being conducted?
This trial has 2 study locations across Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Improving Coronary Vascular Health in Women
RECRUITING · Phase 2
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Rare and Atypical Diabetes Network
RECRUITING
-
Alzheimer"s Imaging Biomarkers in Obesity
RECRUITING
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.